Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
Authors
Keywords
-
Journal
JAMA Neurology
Volume -, Issue -, Pages -
Publisher
American Medical Association (AMA)
Online
2022-02-01
DOI
10.1001/jamaneurol.2021.5216
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alzheimer's disease
- (2021) Philip Scheltens et al. LANCET
- A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images
- (2021) Marco Bucci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
- (2021) Bruno Dubois et al. LANCET NEUROLOGY
- Association of amyloid-β CSF/PET discordance and tau load five years later
- (2020) Juhan Reimand et al. NEUROLOGY
- Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment
- (2020) Philip S. Insel et al. JAMA Neurology
- ApoE4: an emerging therapeutic target for Alzheimer’s disease
- (2019) Mirna Safieh et al. BMC Medicine
- PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases
- (2019) Juhan Reimand et al. Alzheimers Research & Therapy
- Upward drift in cerebrospinal fluid amyloid β 42 assay values for more than 10 years
- (2018) Suzanne E. Schindler et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting
- (2018) Rosebud O. Roberts et al. JAMA Neurology
- Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia
- (2018) Willemijn J. Jansen et al. JAMA Psychiatry
- Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
- (2017) Piotr Lewczuk et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population
- (2017) Daniela Bertens et al. Alzheimers Research & Therapy
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- Unknown
- (2016) ANNALS OF NEUROLOGY
- Unknown
- (2016) Annals of the New York Academy of Sciences
- Prevalence of Amyloid PET Positivity in Dementia Syndromes
- (2015) Rik Ossenkoppele et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
- (2015) Willemijn J. Jansen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CAP—advancing the evaluation of preclinical Alzheimer disease treatments
- (2015) Eric M. Reiman et al. Nature Reviews Neurology
- Age, Sex, andAPOEε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span
- (2015) Clifford R. Jack et al. JAMA Neurology
- Systematic review of methods for individual patient data meta- analysis with binary outcomes
- (2014) Doneal Thomas et al. BMC Medical Research Methodology
- Variability of CSF Alzheimer’s Disease Biomarkers: Implications for Clinical Practice
- (2014) Stephanie J. B. Vos et al. PLoS One
- The A4 Study: Stopping AD Before Symptoms Begin?
- (2014) R. A. Sperling et al. Science Translational Medicine
- Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
- (2013) Keith A. Johnson et al. Alzheimers & Dementia
- Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid
- (2013) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Brain -amyloid load approaches a plateau
- (2013) C. R. Jack et al. NEUROLOGY
- Indicators of amyloid burden in a population-based study of cognitively normal elderly
- (2012) M. M. Mielke et al. NEUROLOGY
- The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers
- (2011) Niklas Mattsson et al. Alzheimers & Dementia
- Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
- (2010) Geert De Meyer ARCHIVES OF NEUROLOGY
- To GEE or Not to GEE
- (2010) Alan E. Hubbard et al. EPIDEMIOLOGY
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
- (2010) Christopher C. Rowe et al. NEUROBIOLOGY OF AGING
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started